<?xml version="1.0" encoding="UTF-8"?>
<gtr:projectOverview xmlns:gtr="http://gtr.ukri.org/api"><gtr:projectComposition><gtr:collaborations><gtr:collaborator url="http://gtr.ukri.org:80/organisation/3A5E126D-C175-4730-9B7B-E6D8CF447F83"><gtr:id>3A5E126D-C175-4730-9B7B-E6D8CF447F83</gtr:id><gtr:name>University College London</gtr:name><gtr:address><gtr:line1>Gower Street</gtr:line1><gtr:line4>London</gtr:line4><gtr:postCode>WC1E 6BT</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator></gtr:collaborations><gtr:leadResearchOrganisation url="http://gtr.ukri.org:80/organisation/2DB7ED73-8E89-457A-A395-FAC12F929C1A"><gtr:id>2DB7ED73-8E89-457A-A395-FAC12F929C1A</gtr:id><gtr:name>University of Edinburgh</gtr:name><gtr:department>Sch of Molecular. Genetics &amp; Pop Health</gtr:department><gtr:address><gtr:line1>Old College</gtr:line1><gtr:line2>South Bridge</gtr:line2><gtr:line3>Mayfield Road</gtr:line3><gtr:line4>Edinburgh</gtr:line4><gtr:postCode>EH8 9YL</gtr:postCode><gtr:region>Scotland</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:typeInd>RO</gtr:typeInd></gtr:leadResearchOrganisation><gtr:organisationRoles><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/2DB7ED73-8E89-457A-A395-FAC12F929C1A"><gtr:id>2DB7ED73-8E89-457A-A395-FAC12F929C1A</gtr:id><gtr:name>University of Edinburgh</gtr:name><gtr:address><gtr:line1>Old College</gtr:line1><gtr:line2>South Bridge</gtr:line2><gtr:line3>Mayfield Road</gtr:line3><gtr:line4>Edinburgh</gtr:line4><gtr:postCode>EH8 9YL</gtr:postCode><gtr:region>Scotland</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>LEAD_RO</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/3A5E126D-C175-4730-9B7B-E6D8CF447F83"><gtr:id>3A5E126D-C175-4730-9B7B-E6D8CF447F83</gtr:id><gtr:name>University College London</gtr:name><gtr:address><gtr:line1>Gower Street</gtr:line1><gtr:line4>London</gtr:line4><gtr:postCode>WC1E 6BT</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole></gtr:organisationRoles><gtr:personRoles><gtr:personRole url="http://gtr.ukri.org:80/person/19CB95C9-BA6C-46C3-AC54-A5051EF7DEB0"><gtr:id>19CB95C9-BA6C-46C3-AC54-A5051EF7DEB0</gtr:id><gtr:firstName>Ralph</gtr:firstName><gtr:surname>Bouhaider</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.ukri.org:80/person/A0769E47-92CB-409E-B1E4-DE12A44FF807"><gtr:id>A0769E47-92CB-409E-B1E4-DE12A44FF807</gtr:id><gtr:firstName>David</gtr:firstName><gtr:surname>Harrison</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.ukri.org:80/person/E56CAE96-E8B2-4100-90AC-727DC450A92D"><gtr:id>E56CAE96-E8B2-4100-90AC-727DC450A92D</gtr:id><gtr:firstName>James</gtr:firstName><gtr:otherNames>Wilson</gtr:otherNames><gtr:surname>Ironside</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.ukri.org:80/person/23ED1FDC-F4BC-42EC-A5C8-1B48D21124A9"><gtr:id>23ED1FDC-F4BC-42EC-A5C8-1B48D21124A9</gtr:id><gtr:firstName>Colin</gtr:firstName><gtr:surname>Smith</gtr:surname><gtr:roles><gtr:role><gtr:name>PRINCIPAL_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole></gtr:personRoles><gtr:project url="http://gtr.ukri.org:80/projects?ref=G0900627"><gtr:id>D5AF80CC-C3AC-45E3-85E3-0A5990862B12</gtr:id><gtr:title>Sudden Death Brain and Tissue Bank</gtr:title><gtr:status>Closed</gtr:status><gtr:grantCategory>Research Grant</gtr:grantCategory><gtr:grantReference>G0900627</gtr:grantReference><gtr:abstractText>Scientific research ultimately aims to improve the health and wellbeing of the public. To achieve this we need to understand the mechanisms of disease such that we may try to develop new treatments. Diseases of the nervous system in particular cause considerable suffering not just to the individual but also to the carers. To better understand disease processes requires the study of animal models, to try and work out the mechanisms of a disease, and then translation of these mechanisms to the human setting. It is in this translation that collected human material, obtained at autopsy with the full consent of the next of kin, is invaluable. It is through the donation of tissues to scientific research that some carers are able to achieve peace of mind that some good may come from the death of a family member. Brain tissue has been collected for many years from cases of long-term neurological diseases such as dementia and multiple sclerosis. In the setting of sudden death, where the bereavement is often felt more acutely due to the unexpectedness of the death and often due to the young age of the individuals involved, donating tissues to scientific research has previously not been an option available to the next of kin. The MRC sudden death brain and tissue bank provides this opportunity. Although many individuals dying suddenly may have no neurological disease at the time of death, their tissues can provide valuable information when compared to brain of an individual with established neurological disease. This control function of normal brain tissue is essential to investigation of all brain disorders and is as important as getting access to tissue from brain disorders.</gtr:abstractText><gtr:technicalSummary>This application relates to the development of a tissue bank derived from sudden death post mortem cases and builds on a pilot study which is currently funded by MRC. We have put in place a mechanism which allows the collection of central nervous system (CNS) and other tissue samples from medico-legal post mortems with the knowledge and full support of the Scottish Executive, the Scottish Crown Office and the Procurators Fiscal in Edinburgh. This will provide an ethically approved resource of human post mortem CNS tissue samples for use by the wider scientific community. The bank will concentrate on control tissues, covering all ages, to provide age-matched controls for other researchers. In addition the bank will store tissues from hard to get disorders, and from disorders which reflect the applicants particular research interests. Where required non-CNS tissues can be banked in response to specific requests from researchers. This bank will provide a unique resource and will address a recognised worldwide shortage of control tissues within the research community.</gtr:technicalSummary><gtr:fund><gtr:end>2011-12-31</gtr:end><gtr:funder url="http://gtr.ukri.org:80/organisation/C008C651-F5B0-4859-A334-5F574AB6B57C"><gtr:id>C008C651-F5B0-4859-A334-5F574AB6B57C</gtr:id><gtr:name>MRC</gtr:name></gtr:funder><gtr:start>2009-11-01</gtr:start><gtr:type>INCOME_ACTUAL</gtr:type><gtr:valuePounds>394984</gtr:valuePounds></gtr:fund><gtr:output><gtr:artisticAndCreativeProductOutputs/><gtr:collaborationOutputs><gtr:collaborationOutput><gtr:collaboratingOrganisation>University College London</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>Institute of Neurology</gtr:department><gtr:description>Key provider of human tissue to genome profiling group</gtr:description><gtr:id>A096102C-ABC5-40B7-A995-4084AB69FA24</gtr:id><gtr:impact>A number of publications have been submitted.</gtr:impact><gtr:outcomeId>P6S21z3cydj-1</gtr:outcomeId><gtr:partnerContribution>Has helped develop a more robust standardised sampling protocol for brain examination and storage.</gtr:partnerContribution><gtr:piContribution>Supply of age matched control human brain tissue</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2008-01-01</gtr:start></gtr:collaborationOutput></gtr:collaborationOutputs><gtr:disseminationOutputs><gtr:disseminationOutput><gtr:description>Public lecture</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>162C057B-F2D9-4E90-A251-A0ABDBCAA69B</gtr:id><gtr:impact>Public lectures given to an audience of public members and invited professionals.

Increased media awareness in Scotland of human brain banking activity.</gtr:impact><gtr:outcomeId>srYmo15onqU</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2009,2010</gtr:year></gtr:disseminationOutput></gtr:disseminationOutputs><gtr:exploitationOutputs/><gtr:furtherFundingOutputs/><gtr:impactSummaryOutputs/><gtr:intellectualPropertyOutputs/><gtr:otherResearchOutputs/><gtr:policyInfluenceOutputs/><gtr:productOutputs/><gtr:researchDatabaseAndModelOutputs/><gtr:researchMaterialOutputs/><gtr:softwareAndTechnicalProductOutputs/><gtr:spinOutOutputs/></gtr:output><gtr:publications><gtr:publication><gtr:id>88B50591-9C80-4D8B-8F63-65417B6CB416</gtr:id><gtr:title>A new index of agonal state for neurological disease.</gtr:title><gtr:parentPublicationTitle>Neuropathology and applied neurobiology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/8d150df90b48d00a43301eb78016c130"><gtr:id>8d150df90b48d00a43301eb78016c130</gtr:id><gtr:otherNames>Sherwood K</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0305-1846</gtr:issn><gtr:outcomeId>YDAyjPe4CbY</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>40808ADC-5433-4886-B24A-976C07D76C9E</gtr:id><gtr:title>RNA integrity in post mortem human variant Creutzfeldt-Jakob disease (vCJD) and control brain tissue.</gtr:title><gtr:parentPublicationTitle>Neuropathology and applied neurobiology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/6a981970c0bb3133c99817ae65ec291d"><gtr:id>6a981970c0bb3133c99817ae65ec291d</gtr:id><gtr:otherNames>Sherwood KR</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0305-1846</gtr:issn><gtr:outcomeId>bAuBjT8jMeD</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>16DCD0B5-CDB0-44ED-8F75-9178373D82DD</gtr:id><gtr:title>Neprilysin and insulin-degrading enzyme levels are increased in Alzheimer disease in relation to disease severity.</gtr:title><gtr:parentPublicationTitle>Journal of neuropathology and experimental neurology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/88461db9bf6fbcf3625d0cb65647f312"><gtr:id>88461db9bf6fbcf3625d0cb65647f312</gtr:id><gtr:otherNames>Miners JS</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>0022-3069</gtr:issn><gtr:outcomeId>KZRejyU8gcQ</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>0C3CD1B9-75B1-4F5C-8F58-DD9872054A22</gtr:id><gtr:title>Higher soluble amyloid beta concentration in frontal cortex of young adults than in normal elderly or Alzheimer's disease.</gtr:title><gtr:parentPublicationTitle>Brain pathology (Zurich, Switzerland)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/c342d14b8329a51d9590ed90c66e6ffb"><gtr:id>c342d14b8329a51d9590ed90c66e6ffb</gtr:id><gtr:otherNames>van Helmond Z</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>1015-6305</gtr:issn><gtr:outcomeId>Eo7LtW17qz9</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>3E1973E0-5880-44DF-8123-6147FEE057EC</gtr:id><gtr:title>Orphan CpG islands identify numerous conserved promoters in the mammalian genome.</gtr:title><gtr:parentPublicationTitle>PLoS genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/2d1ff71cafe0cc736ad7c2ee4100869b"><gtr:id>2d1ff71cafe0cc736ad7c2ee4100869b</gtr:id><gtr:otherNames>Illingworth RS</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>1553-7390</gtr:issn><gtr:outcomeId>SjF1mkYYu7z</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>3A23B1D9-3A9A-4E87-8DCF-D5279F466E6E</gtr:id><gtr:title>Sensitive and specific detection of sporadic Creutzfeldt-Jakob disease brain prion protein using real-time quaking-induced conversion.</gtr:title><gtr:parentPublicationTitle>The Journal of general virology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/920ed8da3cbaa75e635c785b4cc316d8"><gtr:id>920ed8da3cbaa75e635c785b4cc316d8</gtr:id><gtr:otherNames>Peden AH</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0022-1317</gtr:issn><gtr:outcomeId>k7B88b2EuYw</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>9B038068-AE0A-4A2F-A296-45E323F19E99</gtr:id><gtr:title>Evidence that genetic variation in the oxytocin receptor (OXTR) gene influences social cognition in ADHD.</gtr:title><gtr:parentPublicationTitle>Progress in neuro-psychopharmacology &amp; biological psychiatry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/9aee1ee63386515068fab667d68cc059"><gtr:id>9aee1ee63386515068fab667d68cc059</gtr:id><gtr:otherNames>Park J</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0278-5846</gtr:issn><gtr:outcomeId>pjFfLN9erJC</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>5BA6C39E-F15C-406E-BC32-0181E1582AF3</gtr:id><gtr:title>Quality control parameters on a large dataset of regionally dissected human control brains for whole genome expression studies.</gtr:title><gtr:parentPublicationTitle>Journal of neurochemistry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/0fc9b26a4f240104f4f5378597d75aff"><gtr:id>0fc9b26a4f240104f4f5378597d75aff</gtr:id><gtr:otherNames>Trabzuni D</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0022-3042</gtr:issn><gtr:outcomeId>QwsqjjX7b2f</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>89075C5D-35F4-4852-AF8F-043F840833D8</gtr:id><gtr:title>A cytogenetic abnormality and rare coding variants identify ABCA13 as a candidate gene in schizophrenia, bipolar disorder, and depression.</gtr:title><gtr:parentPublicationTitle>American journal of human genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/d192f002d466ef349ce3a6cd9cd6625b"><gtr:id>d192f002d466ef349ce3a6cd9cd6625b</gtr:id><gtr:otherNames>Knight HM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>0002-9297</gtr:issn><gtr:outcomeId>aoo3idxoa79</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>653D66BC-1FC2-403A-AADE-FE6B8C9DCF6F</gtr:id><gtr:title>Regional and developmental brain expression patterns of SNAP25 splice variants.</gtr:title><gtr:parentPublicationTitle>BMC neuroscience</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/0eec540f6db0c1ad30fa68bce5e79ae8"><gtr:id>0eec540f6db0c1ad30fa68bce5e79ae8</gtr:id><gtr:otherNames>Prescott GR</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>1471-2202</gtr:issn><gtr:outcomeId>dJ62UaW8czt</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>B9AEAE11-68A8-41EF-AD2B-13459E794B94</gtr:id><gtr:title>The DRD4 receptor Exon 3 VNTR and 5' SNP variants and mRNA expression in human post-mortem brain tissue.</gtr:title><gtr:parentPublicationTitle>American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/b202123e200987c7884b9109796771e6"><gtr:id>b202123e200987c7884b9109796771e6</gtr:id><gtr:otherNames>Simpson J</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>1552-4841</gtr:issn><gtr:outcomeId>gtJ8TBKyjhW</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>EDB4252E-AFCB-4A77-B040-896890204CAA</gtr:id><gtr:title>Accumulation of insoluble amyloid-? in down's syndrome is associated with increased BACE-1 and neprilysin activities.</gtr:title><gtr:parentPublicationTitle>Journal of Alzheimer's disease : JAD</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/88461db9bf6fbcf3625d0cb65647f312"><gtr:id>88461db9bf6fbcf3625d0cb65647f312</gtr:id><gtr:otherNames>Miners JS</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>1387-2877</gtr:issn><gtr:outcomeId>nK784ZtziMU</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>548734C0-035E-4B9B-9A02-A44DD9F06451</gtr:id><gtr:title>GRIK4/KA1 protein expression in human brain and correlation with bipolar disorder risk variant status.</gtr:title><gtr:parentPublicationTitle>American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/d192f002d466ef349ce3a6cd9cd6625b"><gtr:id>d192f002d466ef349ce3a6cd9cd6625b</gtr:id><gtr:otherNames>Knight HM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>1552-4841</gtr:issn><gtr:outcomeId>HDWpoaGJJ1g</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>CEAB4897-6D80-402C-910F-41D77CDB6708</gtr:id><gtr:title>Expression of cannabinoid CB1 receptors in models of diabetic neuropathy.</gtr:title><gtr:parentPublicationTitle>The Journal of pharmacology and experimental therapeutics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/1809274402a5f43e1a80a137e1986a33"><gtr:id>1809274402a5f43e1a80a137e1986a33</gtr:id><gtr:otherNames>Zhang F</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>0022-3565</gtr:issn><gtr:outcomeId>cwKJk5BrxoA</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>67808340-E2ED-4F66-A897-7B941827B703</gtr:id><gtr:title>Oxytocin receptor (OXTR) does not play a major role in the aetiology of autism: genetic and molecular studies.</gtr:title><gtr:parentPublicationTitle>Neuroscience letters</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/56ada3ea3786a6a31983bfd2ca653851"><gtr:id>56ada3ea3786a6a31983bfd2ca653851</gtr:id><gtr:otherNames>Tansey KE</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0304-3940</gtr:issn><gtr:outcomeId>E2hPVR8GJQY</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>692A0F0D-F459-4C22-8E46-61BB2B4166F1</gtr:id><gtr:title>A two-stage meta-analysis identifies several new loci for Parkinson's disease.</gtr:title><gtr:parentPublicationTitle>PLoS genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/21954146dfa6bdef021f2fa27d03fd93"><gtr:id>21954146dfa6bdef021f2fa27d03fd93</gtr:id><gtr:otherNames>International Parkinson's Disease Genomics Consortium (IPDGC)</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>1553-7390</gtr:issn><gtr:outcomeId>mbqHDKcUgGr</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>F5810C99-E545-4CF7-9DB5-5308E44C756D</gtr:id><gtr:title>Imputation of sequence variants for identification of genetic risks for Parkinson's disease: a meta-analysis of genome-wide association studies.</gtr:title><gtr:parentPublicationTitle>Lancet (London, England)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/1e2d0f395414b93ca8e16b698d9d8d12"><gtr:id>1e2d0f395414b93ca8e16b698d9d8d12</gtr:id><gtr:otherNames>International Parkinson Disease Genomics Consortium</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0140-6736</gtr:issn><gtr:outcomeId>iiy6sA2Xscv</gtr:outcomeId></gtr:publication></gtr:publications><gtr:identifiers><gtr:identifier type="RCUK">G0900627</gtr:identifier></gtr:identifiers><gtr:healthCategories><gtr:healthCategory><gtr:id>3C193D18-12BD-4B15-8347-037BA623E0FF</gtr:id><gtr:percentage>50</gtr:percentage><gtr:text>Mental Health</gtr:text></gtr:healthCategory><gtr:healthCategory><gtr:id>041997EB-CFD8-493D-B0F8-DFA35451D0BE</gtr:id><gtr:percentage>50</gtr:percentage><gtr:text>Neurological</gtr:text></gtr:healthCategory></gtr:healthCategories><gtr:researchActivities><gtr:researchActivity><gtr:id>93C4699B-9E5C-4982-9CCC-EFD5B9712D6E</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>2.6  Resources and infrastructure (aetiology)</gtr:text></gtr:researchActivity></gtr:researchActivities><gtr:researchSubjects/><gtr:researchTopics/><gtr:rcukProgrammes/></gtr:project></gtr:projectComposition></gtr:projectOverview>